We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Predictive Monitoring Safeguards Chronically Ill Patients

By HospiMedica International staff writers
Posted on 09 Sep 2014
Affordable, remote vital-signs monitoring system uses a sophisticated predictive algorithm for cardiac Interpretations on the fly.

The OSTAR A300 remote telehealth vital signs patient monitoring system provides comprehensive, cloud-based monitoring powered by a predictive, three simultaneous interpretations (3SI) algorithm of BP readings to determine cardiac arrhythmia, valve function disease, and coronary artery disease (CAD). More...
The system can be configured based on provider, physician, nurse, chronic disease, drug, and various other accountable care organizations (ACO) metrics, all by using a simple integrated bar code scanner.

Furthermore, the device automatically connects to Wi-Fi and cellphone networks to seamlessly send relevant data, such as BP, interpretive cardiac alerts, pulse oximetry, weight, and pulse rate in real time to an electronic medical record (EMR) and to hospital information exchanges (HIEs) anywhere in the world. The OSTAR A300 remote telehealth vital signs patient monitoring system is a product of OSTAR Healthcare Technology (Vancouver, WA, USA).

“Given the current transformation of healthcare and trend to remote telehealth in the United States, this comprehensive nurse-centered form of remote telehealth changes the game for providers and insurance companies,” commented Paul Markham, MD, President of V3 Healthcare Strategies, a provider of healthcare consulting services. “The concept has the potential to impact shared saving plans in ACOs, while also positively impacting health insurance indicators. The result is reduced cost to healthcare systems and ultimately, to the American healthcare consumer.”

Related Links:

OSTAR Healthcare Technology



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.